Calcitonin gene-related peptide: Vasoactive effects and potential therapeutic role
- 1 June 1996
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 27 (4) , 607-611
- https://doi.org/10.1016/0306-3623(95)00125-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Structure and biology of amylinTrends in Pharmacological Sciences, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Pathogenetic and therapeutic implications of calcitonin-gene-related peptide in the cardiovascular systemTrends in Cardiovascular Medicine, 1991
- The pharmacology of the efferent function of sensory nerves.Journal of Autonomic Pharmacology, 1991
- Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failureThe American Journal of Cardiology, 1991
- Antagonistic effect of human α-CGRP [8–37] on the in vivo regional haemodynamic actions of human α-CGRPBiochemical and Biophysical Research Communications, 1990
- Substance P regulates the vasodilator activity of calcitonin gene-related peptideNature, 1988
- Calcitonin gene-related peptide: Novel neuropeptideLife Sciences, 1986
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985
- Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processingNature, 1983